260 related articles for article (PubMed ID: 10778966)
1. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
Edler D; Hallström M; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
4. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
5. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.
Aschele C; Debernardis D; Tunesi G; Maley F; Sobrero A
Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial.
Sakamoto J; Hamashima H; Suzuki H; Ito K; Mai M; Saji S; Fukushima M; Matsushita Y; Nakazato H
Oncol Rep; 2003; 10(5):1081-90. PubMed ID: 12883662
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
[TBL] [Abstract][Full Text] [Related]
10. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
11. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.
Lenz HJ; Danenberg KD; Leichman CG; Florentine B; Johnston PG; Groshen S; Zhou L; Xiong YP; Danenberg PV; Leichman LP
Clin Cancer Res; 1998 May; 4(5):1227-34. PubMed ID: 9607581
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B
Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
[TBL] [Abstract][Full Text] [Related]
14. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
15. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
16. Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma.
Nehls O; Okech T; Hsieh CJ; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Porschen R; Gregor M; Klump B
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):85-91. PubMed ID: 15629598
[TBL] [Abstract][Full Text] [Related]
17. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
18. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
[TBL] [Abstract][Full Text] [Related]
20. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance.
Yamachika T; Nakanishi H; Inada K; Tsukamoto T; Kato T; Fukushima M; Inoue M; Tatematsu M
Cancer; 1998 Jan; 82(1):70-7. PubMed ID: 9428481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
